NEOBOROCILLINA 16PAST S/Z

NEO BOROCILLINA 1.2 MG + 20 MG PASTIGLIES WITHOUT ZUCCHERO

active ingredients

One pastel contains: Active ingredients - 2.4 DICLOROBENZIL ALCOOL 1.2 mg; - SODIO BENZOATO 20 mg (equivalent to 17 mg of Benzoic Acid). Excipients with known effects: - aspartame 10 mg. For the full list of excipients, see 6.1.

Excellent

Magnesium stearate, colloidal silica moisturizes, levomentol, mint essence, eucalyptus, citral, peppermint, aspartame, granular mannitol (containing mannitol and polyvinylpyrrolidone), mannitol.

Therapeutic indications

Antiseptic of oropharyngeal cable.

Contraindications

Hypersensitivity to active ingredients or any of the excipients. The tablets are contraindicated in children under two years, with predisposition to laryngospasm and convulsions. For the presence of aspartame, the product is contraindicated in case of phenylchetonuria.

Population

Dissolve slowly in the mouth a pastel every 2-3 hours, up to a daily maximum of 8 tablets. Do not exceed the recommended doses.

Conservation

Store at temperature not exceeding 30 ° C.

Warnings

The tablets of Neo Borocillin without sugar, for the presence of menthol, are contraindicated in children under two years of age with predisposition to larynxospasm and convulsions. They must be used with precaution, and under the direct control of the doctor, even in children of higher age. The product does not contain sucrose, it can therefore be assumed by those who must avoid the administration of such sugar. Aspartame: This medicine contains 3 mg of aspartame per pastilla. Aspartame is a source of phenylalanine. It can be harmful if it is suffering from phenylchetonuria, a rare genetic disease that causes the accumulation of phenylalanin because the body fails to dispose of it properly. No clinical or non-clinical studies are available on the use of aspartame in children under 12 weeks of age. Sodium: This medicine contains 3.2 mg of sodium as an active ingredient for pill and 25.5 mg sodium per daily dose equivalent to 1.3% of the maximum daily intake recommended by the WHO which corresponds to 2 g sodium for an adult. The use, especially if prolonged, of oral topical products can give rise to awareness. In this case it is necessary to stop the treatment and consult the doctor for the purpose of establishing suitable therapy. After a short period of treatment without appreciable results, consult your doctor. _.

Interactions

Avoid the contemporary use of other antiseptics.

Effects

They were reported very rarely: reactions of hypersensitivity, feeling of head turning, respiratory failure, glottis edema, vomiting, malaise, sweating, edema of the arms, perioral edema, edema of the eyelids, edema of the face, hives, hemolytic anemia, jaundice. Benzoate sodium is blandly irritating of skin and mucosa. Reporting of suspicious adverse reactions. The reporting of suspicious adverse reactions that occur after the authorization of the medicinal product is important, as it allows continuous monitoring of the benefit/risk ratio of the medicinal product. Healthcare workers are required to report any suspected adverse reaction via the national reporting system at the address https://www.aifa.gov.it/content/segnalazioni-reazioni-avverse.

Overdosing

No overdose cases have been reported. In case of overdosing, appropriate symptomatic treatments must be adopted.

There is no adequate data regarding the use of 2.4 dichlorobenzil alcohol and sodium benzoate in pregnant women. In pregnant women and during breastfeeding, the product should be administered in case of actual need and under the direct control of the doctor.

Source: Farmadati